Received Dec 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
Consumer reports 2 missed doses of TICE BCG; No additional AE reported; This spontaneous report was received from a consumer and referred to themselves, a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant medications were not reported. On an unknown date, the patient started therapy with TICE BCG, powder for intravesical suspension, via intravesical route (indication, dose, frequency, strength, batch/lot number and expiration date were not reported). On an unknown date, the patient reportedly missed 2 doses of TICE BCG. No additional adverse events (AE) reported.